Clinical Trial Update: One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating degarelix versus a comparator for prostate cancer in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED